<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T14:59:53Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10459.1/63260" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10459.1/63260</identifier><datestamp>2024-12-05T22:01:29Z</datestamp><setSpec>com_2072_3622</setSpec><setSpec>col_2072_479130</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes</dc:title>
   <dc:creator>Carbonell, Marc</dc:creator>
   <dc:creator>Castelblanco Echavarría, Esmeralda</dc:creator>
   <dc:creator>Valldeperas, Xavier</dc:creator>
   <dc:creator>Betriu i Bars, M. Àngels</dc:creator>
   <dc:creator>Traveset Maeso, Alicia</dc:creator>
   <dc:creator>Granado Casas, Minerva</dc:creator>
   <dc:creator>Hernández García, Marta</dc:creator>
   <dc:creator>Vázquez, Federico</dc:creator>
   <dc:creator>Martín, Mariona</dc:creator>
   <dc:creator>Rubinat, Esther</dc:creator>
   <dc:creator>Lecube Torelló, Albert</dc:creator>
   <dc:creator>Franch-Nadal, Josep</dc:creator>
   <dc:creator>Fernández i Giráldez, Elvira</dc:creator>
   <dc:creator>Puig-Domingo, Manuel</dc:creator>
   <dc:creator>Avogaro, Angelo</dc:creator>
   <dc:creator>Alonso, Núria</dc:creator>
   <dc:creator>Mauricio Puente, Dídac</dc:creator>
   <dc:subject>Diabetis</dc:subject>
   <dc:subject>Retinopatia diabètica</dc:subject>
   <dc:subject>Aterosclerosi</dc:subject>
   <dc:subject>Diabetes</dc:subject>
   <dc:subject>Diabetic retinopathy</dc:subject>
   <dc:subject>Atherosclerosis</dc:subject>
   <dc:description>Background: Cardiovascular (CV) disease due to atherosclerosis is a major cause of morbidity and mortality in adult patients with diabetes, either type 1 or type 2 diabetes. The aim of the study was to assess the association of the frequency and the burden of subclinical carotid atherosclerotic disease in patients with type 1 diabetes according to the presence and severity of diabetic retinopathy (DR). Methods: A cross-sectional study was conducted in 340 patients with type 1 diabetes (41.5% with DR), and in 304 non-diabetic individuals. All participants were free from previous CV disease and chronic kidney disease (CKD). B-mode carotid ultrasound imaging was performed in all the study subjects. Patients with type 1 diabetes underwent a full eye examination, and DR patients were divided into two groups: mild disease and advanced disease. Results: In the group of patients with type 1 diabetes, the percentage of patients with carotid plaques was higher in those with DR compared with those without DR (44.7% vs. 24.1%, p &lt; 0.001). Patients with DR also presented a higher incidence of ≥ 2 carotid plaques (25.5% vs. 11.1%, p &lt; 0.001). Apart from other traditional cardiovascular risk factors, the presence of advanced stages of DR was independently associated with the presence (p = 0.044) and the burden (≥ 2 carotid plaques; p = 0.009) of subclinical carotid atherosclerosis. Conclusions: In patients with type 1 diabetes without previous CV disease or established CKD, the presence of advanced stages of DR is associated with a higher atherosclerotic burden in the carotid arteries. The presence of DR identifies patients at risk for carotid atherosclerotic disease.</dc:description>
   <dc:description>This research was supported by grants from the Spanish Ministry of Health,&#xd;
the Carlos III National Institute of Health (PI12/0183 and PI15/0625) and&#xd;
European Regional Development Fund (ERDF). CIBER for Diabetes and&#xd;
Associated Metabolic Diseases (CIBERDEM) is an initiative of ISCIII, Spain.</dc:description>
   <dc:date>2018-05-09T11:04:20Z</dc:date>
   <dc:date>2018-05-09T11:04:20Z</dc:date>
   <dc:date>2018-05-04</dc:date>
   <dc:date>2018-05-09T11:04:23Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>https://doi.org/10.1186/s12933-018-0706-z</dc:identifier>
   <dc:identifier>1475-2840</dc:identifier>
   <dc:identifier>http://hdl.handle.net/10459.1/63260</dc:identifier>
   <dc:identifier>http://hdl.handle.net/10459.1/63260</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1186/s12933-018-0706-z</dc:relation>
   <dc:relation>Cardiovascular Diabetology, 2018, vol. 17, núm. 66, p. 1-10</dc:relation>
   <dc:rights>cc-by (c) Carbonell, Marc et al., 2018</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>BioMed Central</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>